Mpox outbreaks pose an increasing health risk at the global level. Our current arsenal of antiviral drugs is lacking and despite the availability of vaccines, the current population is largely susceptible and there are significant challenges to widespread vaccination. The aim of this project is to increase the treatment options for MPOX disease.
Project keywords: Poxviruses, Mpox, proteomics.
Program type: PhD
Research location/building: LEES Building (F22)
School of Life and Environmental Sciences
Here we will identify novel viral and cellular targets for antiviral development and repurposing. This strategy is based on characterising the interactome of poxvirus infection.
This project requires vaccination (VACV).
No associate scholarship opportunity available.
The opportunity ID for this research opportunity is 3565